Press Release
For
Immediate Release Contact: Patricia Sanders
(800) 677-8441
African-American
Men Sought for Prostate Cancer Study
African-American
men with a history of prostate cancer are being sought to participate
in a confidential survey. The data will be used to determine if they
meet the criteria for an historic human genome study on hereditary
prostate cancer. P&E Associates, an independent pharmaceutical
and biogenetic survey organization, is working in partnership with
the National Human Genome Institute (NHGI) at Howard University and
the African American Hereditary Prostate Cancer (AAHPC) Study Network
to locate at least 100 participants by March 31, 2002.
Although more lives are being saved through early detection, African
American men continue to show disproportionately higher numbers of
deaths. Having access to information and funding is critical in fighting
this disease.
"I'm really concerned about prostate cancer. Too many of us are
not getting the message," said U.S. Rep. Maxine Waters. "Our
men should start getting screenings by age 40. If not, some of them
are going to die. My husband gets his check up twice a year."
Recent studies on prostate cancer, done at the National Institute
of Health (NIH), indicate that prostate cancer may run in the families
of black men. In a previous study of 100 men, only one was African
American. In his case, prostate cancer was found in three other family
members.
The new study will allow researchers to examine how the disease specifically
affects African American men. It is the only genetic study of its
type currently being done.
"It is extremely important that more African American families
with prostate cancer be included in national studies so that we can
find out if this disease does run in the family of more African Americans,"
said Patricia Sanders, P&E executive director and wife of prostate
cancer survivor, Ed Sanders.
The AAHPC Study Network was launched in January 1998 with major funding
from the NIH Office of Research on Minority Health, in partnership
with the NHGRI. Additional funding has been provided by the National
Cancer Institute. More information on Howard's recruitment efforts
will appear in the February 2002 issue of Upscale magazine, as well
as in other national publications and on national television.
If you or a member of your family has been diagnosed with prostate
cancer, or you are a doctor treating prostate cancer patients, please
call the toll-free Family Referral Associates Hotline at (800) 677-8441,
or visit the website at www.huhosp.org/hucc/research.htm#7
Prostate
cancer patients or doctors treating men with prostate cancer can complete
the confidential survey online at www.aahpc.resourcez.com.
Thank you for considering this information for print and/or broadcast.
A family referral associate will follow up with you within three days.
To arrange an interview with Dr. Georgia Dunston of Howard or NHGI
scientists working with the AAHPC Study, please call the toll-free
Family Referral Associates Hotline at (800) 677-8441.
Very
truly yours,
Patricia Sanders
Executive Director
P&E Associates